EDIT editasmedicine.com: Bathi mangsa ngarep

Editas Medicine Inc (EDIT) - logo korporat

Editas Medicine, Inc. (EDIT) conducts its development within a stable US environment, shielded from external political risks. However, the company faces intense patent battles in the CRISPR field. The consensus earnings forecast visualizes these trends, where determines the latest valuation metric. The business model relies on full production outsourcing, focusing resources exclusively on research and intellectual property.

EDIT: Proyeksi bathi mangsa ngarep Editas Medicine, Inc. 04.07.2022 - 18.11.2026

Editas Corp - rincian analitis lan metrik utama (EDIT)

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi saham perusahaan:
Analisis komprehensif perusahaan:Editas Corp, EDIT
Produk merek Editas

This indicator reflects the business's expected net income relative to its current market capitalization, allowing for the determination of the asset's degree of overvaluation. By analyzing the forward net income metric, an investor sees the result of daily guidance recalculations, which is critically important for Editas Medicine, Inc. (EDIT), as a stable R&D environment in the US minimizes geopolitical risks when assessing future revenues from gene editing.

Pesaing Editas Medicine, Inc.

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Bathi sing dikarepake RGEN (Repligen Corp.)|Avidity - Bathi mangsa ngarep|CRSP (crisprtx.com) - Bathi forward|WGS: Bathi mangsa ngarep|Proyeksi bathi resik Ultragenyx (RARE)|BEAM: Proyeksi bathi mangsa ngarep|Sarepta Therapeutics, Inc. (SRPT) - Proyeksi bathi mangsa ngarep|TWST (twistbioscience.com) - Proyeksi bathi mangsa ngarep|10x Genomics, Inc. (TXG) - Prakiraan bathi perusahaan|Bathi mangsa ngarep NTLA (Intellia Therapeutics, Inc.)|STOK - Bathi resik sing dikarepake|Bathi sing dikarepake biolifesolutions.com BLFS|Prakiraan bathi perusahaan Wave Life Sciences Corp (WVE)|MAZE - Bathi sing dikarepake|Penghasilan resik sing dikarepake SION (Sionna Therapeutics Inc)|PRME: Proyeksi bathi mangsa ngarep|Taysha - Penghasilan resik sing dikarepake|Bathi sing dikarepake uniQure NV|Prakiraan bathi resik MGTX (MeiraGTx PLC)|Bathi mangsa ngarep RGNX (regenxbio.com)|Solid Biosciences Inc. - Prakiraan bathi resik|Bathi sing dikarepake Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Bathi resik sing dikarepake|BNTC - Bathi sing dikarepake|Design Pharma - Bathi resik mangsa ngarep|RCKT (Rocket Pharmaceuticals Inc) - Bathi mangsa ngarep|4D Molecular Therapeutics (FDMT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Lexeo Therapeutics, Inc.|Bathi resik sing dikarepake Korro Bio, Inc. KRRO|Bathi sing dikarepake Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CDXS (Codexis, Inc.)|Prakiraan bathi perusahaan sangamo.com (SGMO)|nautilus.bio - Proyeksi bathi mangsa ngarep|Metagenomi (MGX) - Bathi mangsa ngarep|DTIL: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Exicure (XCUR)|Bathi sing dikarepake Celsion Corporation (IMNN)|PHIO - Bathi resik sing dikarepake|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep